Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Move to help Indian cos challenge patent holders & sell low-cost version of high-priced drugs The government will make public details of every medicine patented in the country to bring transparency
New Delhi: Antibiotic shots, being used at will to make chickens fatter or shrimps bigger, will be soon regularized. For the first time, National Policy for Containment of Antimicrobial Resistance has put a cap on how much antibiotics can be pumped into seafood or poultry products, including shrimps or fish …
Mumbai: US-based pharma biggie Merck and Mumbaibased Sun Pharma have entered into a strategic collaboration to jointly develop, manufacture and commercialize new combinations of innovative branded generics (affordable versions sold under a brand name) in emerging markets. The joint venture, with
The government has decided to retain the flexibility it has in issuing compulsory licences for patented drugs in case of public health emergency and not issue specific guidelines on when it can act.
MUMBAI: Despite crores of rupees being pumped into the healthcare machinery, the state has failed to stock adequate essential drugs at health centres. It is this shortage of drugs that experts are attributing to the state's rising infant mortality rate, which is much higher than seven other states, including Mizoram …
New Delhi: The government is getting serious about curbing irrational use of antibiotics. The Union health ministry has formalized a National Policy for Containment of Antibiotic Resistance which is awaiting health minister Ghulam Nabi Azad
Only a global effort to stop misuse of antibiotics will save mankind from drug-resistant microbes We have been hearing a lot about superbugs in recent years for both right and wrong reasons. Right, because these bugs are difficult to treat with antibiotics, the wonder drugs of modern medicine, and, therefore, …
Several global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India, making them vulnerable to penalties and potentially allowing local firms to make and sell low-cost version of their drugs, local patent lawyers said. To ensure that the patents granted in …
The framework for antibiotic discovery, development and approval is broken — only four new classes of antibiotics have been launched in the past 40 years. The World Health Organization forecasts a disaster due to the rapid, unchecked increase in antimicrobial resistance and has just announced a policy to combat its …
The State Drug Control Administration (SDCA) began recalling medicines that use the Gatifloxacin and Tegaserod formulations as the Drugs Controller General of India has banned the two drugs. The decision to ban these drugs was taken following the recommendations of the drug technical advisory committee, as the said drugs have …
Despite regulatory restrictions, off-label marketing of pharmaceutical products has been common in the US. However, the scope of off-label marketing remains poorly characterized. We developed a typology for the strategies and practices that constitute off-label marketing.
Antimicrobial resistance in pathogens causing important communicable diseases has become a matter of great public health concern globally including India. Resistance has emerged even to newer, more potent antimicrobial agents like carbapenems. The factors responsible for this are widespread use and availability of practically all the antimicrobials across the counter …
Moga: Scientists have called upon medical scientists and pharmacists in particular to regulate the use of drugs to minimise their side affects and improve the quality of life. They were addressing pharmacists and young scientists in the two-day national seminar on
LICENCES of public-sector, vaccine-manufacturing units were restored more than a year ago. But the units are yet to resume supply of vaccines to the Centre’s Universal Immunisation Programme, and it will not happen any time soon if one were to believe activists. The Central Research Institute (CRI) at Kasauli in …
